Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Päätekijät: Macarena Orejudo (Tekijä), Raul R. Rodrigues-Diez (Tekijä), Raquel Rodrigues-Diez (Tekijä), Ana Garcia-Redondo (Tekijä), Laura Santos-Sánchez (Tekijä), Javier Rández-Garbayo (Tekijä), Pablo Cannata-Ortiz (Tekijä), Adrian M. Ramos (Tekijä), Alberto Ortiz (Tekijä), Rafael Selgas (Tekijä), Sergio Mezzano (Tekijä), Carolina Lavoz (Tekijä), Marta Ruiz-Ortega (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...